Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June
June 09 2021 - 8:00AM
Business Wire
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy
company committed to cures for blood cancers and serious blood
diseases, today announced that company management will present its
corporate highlights at the following investor conferences in
June:
- JMP Securities Life Sciences Conference, June 16-17, 2021. In a
fireside chat at 12:30 p.m. ET on June 16, 2021, management will
discuss a corporate overview for 2021 with a special focus on
multiple growth opportunities driven by advances in the development
of omidubicel, a potentially life-saving NAM-enabled cell therapy
with positive Phase 3 clinical data, and based on encouraging
preliminary clinical results, NAM-enabled natural killer (NK) cell
immunotherapies including GDA-201.
- A.G.P. Summer Healthcare Symposium, June 17, 2021. The company
will present its 2021 corporate highlights to investors in
one-on-one meetings on June 17, 2021.
In the fourth quarter of 2021, Gamida Cell is targeting a BLA
submission for omidubicel, the first potential approval of a cell
therapy for blood cancer patients in need of an allogeneic bone
marrow transplant. In the second half of 2021, the Company is
planning an IND submission to support the initiation of a Phase 1/2
clinical study of cryopreserved, off-the-shelf GDA-201 in patients
with follicular and diffuse large b-cell lymphomas.
A live webcast of the JMP Securities fireside chat will be
available on the “Investors & Media” section of Gamida Cell’s
website at www.gamida-cell.com, and will be available for at least
14 days following the event.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to
cures for patients with blood cancers and serious blood diseases.
We harness our NAM-enabled cell platform to create potential
therapies with a curative approach for cancer patients in need of
better treatment options. For additional information, please visit
www.gamida-cell.com or follow Gamida Cell on LinkedIn or Twitter at
@GamidaCellTx.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210609005071/en/
For investors: Stephanie Ascher Stern Investor Relations, Inc.
stephanie.ascher@sternir.com 1-212-362-1200
For media: Rhiannon Jeselonis Ten Bridge Communications
rhiannon@tenbridgecommunications.com 1-978-417-1946
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Apr 2023 to Apr 2024
